Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish oil intravenous lipid emulsion after esophagectomy
2016-004978-17Phase 4Completed
- Sponsor
- Bellvitge University Hospital
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid in esophageal cancer (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Interleukin-6. Started May 2017; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2016-004978-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004978-17.